Drug application
SULFONAMIDES DUPLEX (SULFADIAZINE, SULFAMERAZINE)
Drugs@FDA NDA 006317 · LILLY
Key facts
| Drug name | SULFONAMIDES DUPLEX |
|---|---|
| Active ingredients | SULFADIAZINE, SULFAMERAZINE |
| Application type | NDA |
| Application number | 006317 |
| Company | LILLY |
| Dosage forms | SUSPENSION, ORAL |
| Strength | 250MG/5ML;250MG/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.